177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Clinical trial NCT05570994 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05570994
Sponsor: British Columbia Cancer Agency
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Prostate Cancer Metastatic Castrate Resistant Prostate Cancer

Start date: 2024-01-01
Primary completion: 2026-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.